01
Cash & equivalents increased 64.8%
Cash & equivalents changed +64.8% from the comparable as-filed period.
$12.1M→$20.0MComparable → current
· Pharmaceutical Preparations
RESEARCH SNAPSHOTCNS Pharmaceuticals, Inc.'s latest supported as-filed period reports net income of -$2.6M, 9.0% below the comparable as-filed period. Every value below links to its SEC accession and metric lineage.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
Cash & equivalents changed +64.8% from the comparable as-filed period.
Net income changed -9.0% from the comparable as-filed period.
Operating income changed -12.1% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Each point keeps the date investors could first observe it and its accession.
CNSP · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001683168-26-006553SEC ↗4Aug 18, 2026Period Aug 14, 20260001683168-26-006552SEC ↗10-QAug 12, 2026Period Jun 30, 20260001683168-26-006224SEC ↗8-KJul 2, 2026Period Jul 2, 20260001683168-26-005233SEC ↗4May 20, 2026Period May 18, 20260001683168-26-004145SEC ↗10-QMay 14, 2026Period Mar 31, 20260001683168-26-003847SEC ↗8-KMay 4, 2026Period May 4, 20260001683168-26-003432SEC ↗Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
| Filed / transacted | Reporting owner | Semantics | Shares | Price | Notional | Source |
|---|---|---|---|---|---|---|
| May 18, 2026Filed Aug 18, 2026 | Fisher MichalDirector | Open Market PurchaseDirect | 2,000 | $5 | $10,000 | Form 4 ↗ |
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Research & development changed +2.9% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-06-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001683168-26-003374